The Boston, MA law firm Shapiro Haber & Urmy LLP wishes to notify InVivo
investors that it filed the only class action securities fraud suit that
has been brought against InVivo Therapeutics Holdings Corp. (“InVivo”)
(OTCBB: NVIV), a Cambridge, MA company, and its former Chairman and CEO
for violations of federal securities laws. The firm filed the complaint
on July 31, 2014 in the United States District Court for the District of
Massachusetts, entitled Battle Construction Co., Inc. v. InVivo
Therapeutics Holdings Corp., et al., C.A. No. 14-cv-13180.
Numerous press releases have been issued by different law firms
announcing the suit, but Shapiro Haber & Urmy LLP is the only firm that
has conducted a careful investigation and filed suit to recover money
for investors. The Complaint alleges that the Defendants made false and
misleading statements about the FDA’s approval of a clinical trial and
the time for completion of the trial and submission of data to the FDA.
The Complaint alleges that these misstatements and omissions by
Defendants misrepresented and/or omitted material facts to the investing
public, in violation of Sections 10(b) and 20(a) of the Securities
Exchange Act.
The class action is brought on behalf of all persons and entities who
purchased common stock of InVivo during the period from April 5, 2013
through August 26, 2013.
If you are interested in joining the suit, or you wish to register with
the firm as a member of the class, please contact the firm at the
telephone numbers below or by email.
More information about the law firm and its qualifications is available
at www.shulaw.com.
The firm has extensive experience litigating securities fraud class
actions and has the highest rating of AV from Martindale Hubbell.
Partner Thomas Shapiro, who prepared the InVivo complaint, has been
recognized as one of the top 100 lawyers in New England.
Copyright Business Wire 2014